TrianglePUBLICATIONS · 15908649
Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2005 May 20
- First author
- Berg SL
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Berg SL
- type
- Author
- name
- Blaney SM
- type
- Author
- name
- Devidas M
- type
- Author
- name
- Lampkin TA
- type
- Author
- name
- Murgo A
- type
- Author
- name
- Bernstein M
- type
- Author
- name
- Billett A
- type
- Author
- name
- Kurtzberg J
- type
- Author
- name
- Reaman G
- type
- Author
- name
- Gaynon P
- type
- Author
- name
- Whitlock J
- type
- Author
- name
- Krailo M
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Berg SL
- type
- Author
- name
- Blaney SM
- type
- Author
- name
- Devidas M
- type
- Author
- name
- Lampkin TA
- type
- Author
- name
- Murgo A
- type
- Author
- name
- Bernstein M
- type
- Author
- name
- Billett A
- type
- Author
- name
- Kurtzberg J
- type
- Author
- name
- Reaman G
- type
- Author
- name
- Gaynon P
- type
- Author
- name
- Whitlock J
- type
- Author
- name
- Krailo M
- type
- Author
- bibliography ids
- nci-bib-bfb9ee231ea85f581fda86e8
- book metadata
- content sha256
- daff525791a520f7ef3b013b9d21070b46abb79158760764a6782532fee992dd
- document type
- citation
- dois
- 10.1200/JCO.2005.03.426
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:15908649
- immutable id
- pubmed:15908649@daff525791a520f7ef3b013b9d21070b46abb79158760764a6782532fee992dd
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- Source null
- issn print
- 0732-183X
- issue
- 15
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3376-82
- volume
- 23
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 15908649
- provenance
- batch id
- c1587c4840dc976b65de
- provider
- NCBI PubMed ESummary
- record sha256
- cf4b8f5d0d309f363e06a978414ea3275eca985ba33f05178d392743e691fa95
- response sha256
- 1dc03bdea4f6d08d05f92b6e458fb2ffa8a3c523f1f3e268fece6307fc70dead
- retrieved at
- 2026-09-09T23:45:59.852120+00:00
- publication date
- display
- 2005 May 20
- precision
- day
- year
- 2005
- publication types
- Clinical Trial
- Clinical Trial, Phase II
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group.
Preserved source evidence · Not medical advice